The Stain of the Spotless Mind: Policy Recommendations for Memory Erasure
This post was written as part of a class assignment from students who took a neuroethics course with Dr. Rommelfanger in Paris of Summer 2016.![]() |
| Image courtesy of Flikr |
Memories were not always considered malleable; it was not until the 1960s that experiments in rats challenged the ideas that memories could be subjected to further modification, given the right conditions (Singer 2009). Fearful memories are made when emotionally salient events are labeled by the amygdala in the brain as emotionally significant and sent to the hippocampus for consolidation, strengthening synaptic connections into what will become a memory (Lu 2015). However, these connections can be disrupted; current therapies for post-traumatic stress disorder (PTSD) aim to block reconsolidation after reactivating these traumatic fear-based memories or promote extinction learning, a re-conditioning of fearful stimuli (Guistino et al. 2015). These are precisely the pathways targeted by drugs such as propranolol, a repurposed beta blocker that has been given hyperbolic names such as “the magic pill” or “a drug to cure fear” for its ability to alter memory reconsolidation, even allowing people with arachnophobia to touch spiders during exposure therapy (Scutti 2013; Friedman 2016). On the non-pharmacological front, developments in areas such as optogenetics may allow for the precise targeting of light sensitive proteins of the brain’s fear circuitry; devices that electrically stimulate the brain, the veritable alphabet soup of TMS, DBS, and tDCS, may strength exposure based therapy (Milad et al. 2014).
![]() |
| Image courtesy of Wikicommons |
The 18th century Scottish philosopher David Hume defined the self as the connections within a discrete “bundle” of sensations and experiences; he believed that any changes in memory would be a change to the very self (Gentile 2010). Contrary to this view, some modern ethicists view memory erasure as a way to return to what is closer to the true self than the individual would have been living life dominated by the traumatic memory (Kolber 2011). Implicit in this assumption is that there is a self that is wholly independent from life circumstances; that character is static, and is not built by repeated actions and thoughts. Erler (2010) states that even core aspects of the “true self” such as personality and disposition can change over time despite being independent of choice; thus, it is inaccurate to appeal the true self as an abstract “essence.” Nevertheless, it is important to maintain authenticity by rejecting frivolous use of memory dampening technology. Erler (2010) states that it is inauthentic to change one’s memories such that “they change themselves in a way that distorts their perception of the world.” He goes on to offer the example of Liz, whose ability to unconditionally forgive the bullies of her adolescence following memory erasure would be contrary to the real harm she suffered that informed her reluctant nature, regardless of the nobility of the sentiment (Erler 2010). Indeed, emotions reveal deeply held concerns that are a product of one’s experiences and inform movement through moral space (Kabasenche 2007).
References
Aoki, C.R.A. 2008. Rewriting my autobiography: The legal and ethical implications of memory-dampening agents. Bulletin of Science Technology & Society 28(4): 349-359. doi: 10.1177/0270467608320223
Bell, J.A. 2007. Preventing Post-Traumatic Stress disorder or pathologizing bad memories. American Journal of Bioethics 7(9): 29-30. doi:10.1080/15265160701518540
Chandler J.A., Mogyoros, A., Rubio, T.A., & Racine, E. 2013. Another look at the legal and ethical consequences of pharmacological memory dampening: The case of sexual assault. The Journal of Law, Medicine, and Ethics 41(4):859-71. doi: 10.1111/jlme.12096.
Erler, A. 2011.Does memory modification threaten our authenticity. Neuroethics 4:235-249.
doi:10.1007/s12152-010-9090-4
Friedman, R.A. 2016. A drug to cure fear. The New York Times, January 22. Available at: http://www.nytimes.com/2016/01/24/opinion/sunday/a-drug-to-cure-fear.html?_r=0 (accessed on June 19, 2016).
Gentile, S. 2010. If we erase our memories, do we erase ourselves. Public Broadcasting Service, November 24. Available at: http://www.pbs.org/wnet/need-to-know/the-daily-need/if-we-erase-our-memories-do-we-erase-ourselves/5322/ (accessed June 19, 2016).
Hoffmann, S.G. 2014. D-cycloserine for Treating Anxiety Disorders: Making Good Exposures Better and Bad Exposures Worse. Depression and Anxiety 31(3):175-177. doi:10.1002/da.22257
Giustino, T.F., Fitzgerald, P.J., & Maren, S. 2016. Revisiting propranolol and PTSD: Memory erasure or extinction enhancement. Neurobiology of Learning and Memory 130:26-33. doi:10.1016/j.nlm.2016.01.009
Kabasenche , W.P. 2007. Emotions, memory suppression, and identity. American Journal of Bioethics 7(9): 33-34. doi: 10.1080/15265160701518581
Kolber, A. 2006. Therapeutic forgetting: The legal and ethical implications of memory dampening. Vanderbilt Law Review 59:1561-1627.
Kolber, A. 2011. Give memory-altering drugs a chance. Nature 476: 275-276. doi:10.1038/476275a
Liao, S.M. & Sandberg, A. 2008. The normativity of memory modification. Neuroethics 1:85-99. doi: 10.1007/s12152-008-9009-5
Lu, S. 2015. Erasing bad memories. Monitor on Psychology 46(2):42.
McAdams, D. P. 2006. The redemptive self: Stories Americans live by. New York, NY: Oxford University Press.
Milad, M.R., Rosenbaum, B.L., & Simon, N.M. 2014. Neuroscience of fear extinction: Implications for assessment and treatment of fear-based and anxiety related disorders. Behavior Research and Therapy 62: 17-23. doi:10.1016/j.brat.2014.08.006
Scutti, S. Memory, forgetting and propranolol: Should some experiences never be recalled. Medical Daily, July 8. Available at: http://www.medicaldaily.com/memory-forgetting-and-propranolol-should-some-experiences-never-be-recalled-video-247469 (accessed on June 19, 2016).
Singer, E. 2009. Manipulating Memory. MIT Technology Review, April 21. Available at: https://www.technologyreview.com/s/413109/manipulating-memory/ (accessed on June 19, 2016).
Tenenbaum, E.M. & Reese, B. 2007. Memory-altering drugs: Shifting the paradigm of informed consent. The American Journal of Bioethics 7(9): 40-42. doi:10.1080/15265160701518649
Wallace, L. 2011. Even if we could erase bad memories, should we. The Atlantic, May 10. Available at: http://www.theatlantic.com/health/archive/2011/05/even-if-we-could-erase-bad-memories-should-we/238444/ (accessed on June 19, 2016).
Want to cite this post?
Leistikow, P. (2016). The Stain of the Spotless Mind: Policy Recommendations for Memory Erasure. The Neuroethics Blog. Retrieved on , from http://www.theneuroethicsblog.com/2016/09/the-stain-of-spotless-mind-policy.html


Thanks for that interesting post, just worth to note, that , there are very well established criminal procedures, where an early testimony can be given or be questioned , so, such erasure of memory as presented, can no longer interrupt justice making process. It can be done, even with sophisticated devices (imaging and screening) and enhance even the evidentiary reliability of the evidences in a given crime investigated . So, if full consent would be given (by the victim), and, the memory is causing substantial clinical disorders (flashbacks, delusional thoughts and senses, intrusive nightmares and so forth …. ) Preliminary procedure, can reconcile both: justice, and: curing patients wittingly .
Thanks
ReplyDelete
nice
ReplyDelete